Morgan Stanley’s Columbia Research Enhanced Core ETF RECS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$305M Buy
7,054,701
+850,152
+14% +$36M 0.02% 794
2026
Q1
$242M Buy
6,204,549
+988,707
+19% +$40.1M 0.01% 849
2025
Q4
$213M Buy
5,215,842
+1,265,928
+32% +$51.5M 0.01% 910
2025
Q3
$159M Buy
3,949,914
+548,851
+16% +$21.2M 0.01% 1064
2025
Q2
$125M Buy
3,401,063
+1,003,167
+42% +$34M 0.01% 1160
2025
Q1
$79.6M Buy
2,397,896
+705,023
+42% +$24.5M 0.01% 1418
2024
Q4
$58.6M Buy
1,692,873
+517,730
+44% +$18.2M ﹤0.01% 1696
2024
Q3
$39.8M Buy
1,175,143
+691,888
+143% +$22.7M ﹤0.01% 2070
2024
Q2
$15.6M Buy
483,255
+469,312
+3,366% +$14.6M ﹤0.01% 2937
2024
Q1
$432K Buy
13,943
+2,341
+20% +$68.5K ﹤0.01% 5378
2023
Q4
$321K Sell
11,602
-200
-2% -$5.22K ﹤0.01% 5513
2023
Q3
$297K Buy
+11,802
New +$306K ﹤0.01% 5406

Other funds holding RECS

Morgan Stanley's RECS Position: Q2 2026 in Review

Morgan Stanley increased its Columbia Research Enhanced Core ETF (RECS) stake by 14% in Q2 2026, buying an estimated $36M and bringing the position to 7,054,701 shares worth $305M. The position accounts for 0.02% of the portfolio, ranked #794.

Morgan Stanley first reported a position in RECS in Q3 2023 and has held it in 12 quarters since. 185 funds tracked by Wall St. Rank hold RECS as of Q2 2026.

  • Morgan Stanley held 7,054,701 shares of Columbia Research Enhanced Core ETF worth $305M as of Q2 2026.
  • Morgan Stanley bought 850,152 Columbia Research Enhanced Core ETF shares in Q2 2026, an estimated $36M.
  • Columbia Research Enhanced Core ETF made up 0.02% of Morgan Stanley's portfolio in Q2 2026, its #794 holding.
  • Morgan Stanley first reported a position in Columbia Research Enhanced Core ETF in Q3 2023 and has held it in 12 quarters since.
  • 185 funds tracked by Wall St. Rank held Columbia Research Enhanced Core ETF as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.